PARC is a research group lead by Professor Guy Ludbrook, conducting specialised research into multiple disciplines.
The purpose of PARC is to undertake clinical research for the pharmaceutical and biotech industries, and to provide a safe and suitable environment for the conduct of academic clinical studies. PARC has extensive experience in clinical research, including products in early phase of development that require specialised management.
PARC has extensive experience in studies that engage in a broad range of therapeutic areas, and across various development stages. The location in the Royal Adelaide Hospital and University heritage allows access to a large number of specialist clinicians, many who require a unique and flexible facility such as PARC to conduct their clinical research studies.
The PARC facility operates 24 hours a day, 7 days a week. This allows for intensive monitoring for narrow therapeutic margin (higher risk) therapies, and the non-hospital allocated beds allow for overnight and participant studies to be conducted with ease, providing greater flexibility to sponsors and clinicians.